Results 301 to 310 of about 7,950,605 (408)

The oxidative pathway of carbohydrate metabolism in Escherichia coli. 2. Quantitative studies of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase [PDF]

, 1953
Dwight B. McNair Scott, Shira Cohen
openalex   +1 more source

Genes and molecular pathways underpinning ciliopathies

Nature reviews. Molecular cell biology, 2017
Jeremy F. Reiter, M. Leroux
semanticscholar   +1 more source

Uncovering dendritic cell specific biomarkers for diagnosis and prognosis of cardiomyopathy using single cell RNA sequencing and comprehensive bioinformatics analysis. [PDF]

Sci Rep
Rahman MM, Rahman MH, Hossain MA, Islam KM, Apu PS, Khan M, Kibria MG, Ansari SA, Humayoo M.   +8 more
europepmc   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

Tissue- and Condition-Specific Biosynthesis of Ascorbic Acid in <i>Glycine max</i> L.: Insights from Genome-Wide Analyses of Pathway-Encoding Genes, Expression Profiling, and Mass Fraction Determination. [PDF]

Int J Mol Sci
Aziz S, Germano TA, Sousa Do Nascimento MADS, Dos Santos CP, Arnholdt-Schmitt B, de Miranda MRA, Gomes MMA, Mazorra Morales LM, Ayub RA, Oliveira JG, Costa JH.   +10 more
europepmc   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Histological Study on the Cardiac Conducting Systems in the Atrial Portion of the Dog's Heart (3) : ON THE SPECIFIC PATHWAYS CONDUCTED BETWEEN THE SINUS NODE AND THE TAWARA NODE

, 1959
M Oosawa
openalex   +2 more sources

Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC. [PDF]

Sci Rep
Liu X, Liu W, Wu Y, Wang Y, Jiang Q, Li Y, Li H, Hao L.   +7 more
europepmc   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

Molecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny   +18 more
wiley   +1 more source

Descending Spinal Pathway Subserving the Adrenaline Secretion of the Adrenal

, 1958
Tatuzi Suzuki, I Tanaka, Chikamasa Ninagawa, Teruo Nakamura, SHIGEMI FUJISAKI   +4 more
openalex   +2 more sources